BAFF, APRIL and their receptors: Structure, function and signaling

Seminars in Immunology

Volumn 18, Issue 5, 2006, Pages 263-275

  Bossen, Claudia ^a   Schneider, Pascal ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

B cells; BAFF; Signaling; Splice variants; Structure

Indexed keywords

APRIL PROTEIN; BAFF PROTEIN; BIM PROTEIN; CD40 LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; LIGAND; MEMBRANE PROTEIN; PROTEIN BCL 2; PROTEIN KINASE C DELTA; UNCLASSIFIED DRUG;

B LYMPHOCYTE ACTIVATION; CELL MATURATION; CELLULAR DISTRIBUTION; HUMAN; MUTATIONAL ANALYSIS; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; SPECIES DIFFERENCE; STRUCTURE ANALYSIS; T LYMPHOCYTE;

ALTERNATIVE SPLICING; ANIMALS; ANTIGEN PRESENTATION; APOPTOSIS; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-CELL MATURATION ANTIGEN; B-LYMPHOCYTES; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MICE; MODELS, MOLECULAR; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPPING; PROTEIN KINASE C-DELTA; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 33747837100     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2006.04.006     Document Type: Review

References (99)

1. Hahne M., Kataoka T., Schroter M., Hofmann K., Irmler M., Bodmer J.L., et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 188 (1998) 1185-1190
2. Shu H.B., Hu W.H., and Johnson H. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukocyte Biol 65 (1999) 680-683
3. Schneider P., MacKay F., Steiner V., Hofmann K., Bodmer J.L., Holler N., et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med 189 (1999) 1747-1756
4. Moore P.A., Belvedere O., Orr A., Pieri K., LaFleur D.W., Feng P., et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285 (1999) 260-263
5. von Bulow G.U., and Bram R.J. NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science 278 (1997) 138-141
6. Thompson J.S., Bixler S.A., Qian F., Vora K., Scott M.L., Cachero T.G., et al. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293 (2001) 2108-2111
7. Yan M., Brady J.R., Chan B., Lee W.P., Hsu B., Harless S., et al. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency. Curr Biol 11 (2001) 1547-1552
8. Laabi Y., Gras M.P., Carbonnel F., Brouet J.C., Berger R., Larsen C.J., et al. A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma. Embo J 11 (1992) 3897-3904
9. Ingold K., Zumsteg A., Tardivel A., Huard B., Steiner Q.G., Cachero T.G., et al. Identification of proteoglycans as the APRIL-specific binding partners. J Exp Med 201 (2005) 1375-1383
10. Hendriks J., Planelles L., de Jong-Odding J., Hardenberg G., Pals S.T., Hahne M., et al. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ 12 (2005) 637-648
11. Bischof D., Elsawa S.F., Mantchev G., Yoon J., Michels G.E., Nilson A., et al. Selective activation of TACI by syndecan-2. Blood (2005)
12. Schneider P. The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol 17 (2005) 282-289
13. Ng L.G., Mackay C.R., and Mackay F. The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 42 (2005) 763-772
14. Kalled S.L., Ambrose C., and Hsu Y.M. The biochemistry and biology of BAFF APRIL and their receptors. Curr Dir Autoimmun 8 (2005) 206-242
15. Liu Y., Xu L., Opalka N., Kappler J., Shu H.B., and Zhang G. Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands. Cell 108 (2002) 383-394
16. Zhukovsky E.A., Lee J.O., Villegas M., Chan C., Chu S., and Mroske C. TNF ligands: is TALL-1 a trimer or a virus-like cluster?. Nature 427 (2004) 413-414 (discussion 414)
17. Cachero T.G., Schwartz I.M., Qian F., Day E.S., Bossen C., Ingold K., et al. Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor). Biochemistry 45 (2006) 2006-2013
18. Gavin A.L., Ait-Azzouzene D., Ware C.F., and Nemazee D. DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine BAFF. J Biol Chem 278 (2003) 38220-38228
19. Gavin A.L., Duong B., Skog P., Ait-Azzouzene D., Greaves D.R., Scott M.L., et al. deltaBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models. J Immunol 175 (2005) 319-328
20. Vogt G., Chapgier A., Yang K., Chuzhanova N., Feinberg J., Fieschi C., et al. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet 37 (2005) 692-700
21. Gras M.P., Laabi Y., Linares-Cruz G., Blondel M.O., Rigaut J.P., Brouet J.C., et al. BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes. Int Immunol 7 (1995) 1093-1106
22. Kelly K., Manos E., Jensen G., Nadauld L., and Jones D.A. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res 60 (2000) 1021-1027
23. Yan M., Wang L.C., Hymowitz S.G., Schilbach S., Lee J., Goddard A., et al. Two-amino acid molecular switch in an epithelial morphogen that regulates binding to two distinct receptors. Science 290 (2000) 523-527
24. Pradet-Balade B., Medema J.P., Lopez-Fraga M., Lozano J.C., Kolfschoten G.M., Picard A., et al. An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. Embo J 21 (2002) 5711-5720
25. Shu H.B., and Johnson H. B cell maturation protein is a receptor for the tumor necrosis factor family member TALL-1. Proc Natl Acad Sci USA 97 (2000) 9156-9161
26. Hatzoglou A., Roussel J., Bourgeade M.F., Rogier E., Madry C., Inoue J., et al. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1 TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J Immunol 165 (2000) 1322-1330
27. Xu L.G., and Shu H.B. TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kappa B activation and IL-10 production. J Immunol 169 (2002) 6883-6889
28. Ni C.Z., Oganesyan G., Welsh K., Zhu X., Reed J.C., Satterthwait A.C., et al. Key molecular contacts promote recognition of the BAFF receptor by TNF receptor-associated factor 3: implications for intracellular signaling regulation. J Immunol 173 (2004) 7394-7400
29. Hymowitz S.G., Patel D.R., Wallweber H.J., Runyon S., Yan M., Yin J., et al. Structures of APRIL-receptor complexes: like BCMA, TACI employs only a single cysteine-rich domain for high affinity ligand binding. J Biol Chem 280 (2005) 7218-7227
30. Dillon S.R., Gross J.A., Ansell S.M., and Novak A.J. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov (2006)
31. Liu Y., Hong X., Kappler J., Jiang L., Zhang R., Xu L., et al. Ligand-receptor binding revealed by the TNF family member TALL-1. Nature 423 (2003) 49-56
32. Kim H.M., Yu K.S., Lee M.E., Shin D.R., Kim Y.S., Paik S.G., et al. Crystal structure of the BAFF-BAFF-R complex and its implications for receptor activation. Nat Struct Biol 10 (2003) 342-348
33. Bodmer J.L., Schneider P., and Tschopp J. The molecular architecture of the TNF superfamily. Trends Biochem 27 (2002) 19-26
34. Gordon N.C., Pan B., Hymowitz S.G., Yin J., Kelley R.F., Cochran A.G., et al. BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site. Biochemistry 42 (2003) 5977-5983
35. Patel D.R., Wallweber H.J., Yin J., Shriver S.K., Marsters S.A., Gordon N.C., et al. Engineering an APRIL-specific B cell maturation antigen. J Biol Chem 279 (2004) 16727-16735
36. Reichlin A., Hu Y., Meffre E., Nagaoka H., Gong S., Kraus M., et al. B cell development is arrested at the immature B cell stage in mice carrying a mutation in the cytoplasmic domain of immunoglobulin beta. J Exp Med 193 (2001) 13-23
37. Schiemann B., Gommerman J.L., Vora K., Cachero T.G., Shulga-Morskaya S., Dobles M., et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 293 (2001) 2111-2114
38. Gross J.A., Dillon S.R., Mudri S., Johnston J., Littau A., Roque R., et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity 15 (2001) 289-302
39. Gorelik L., Cutler A.H., Thill G., Miklasz S.D., Shea D.E., Ambrose C., et al. Cutting edge: BAFF regulates CD21/35 and CD23 expression independent of its B cell survival function. J Immunol 172 (2004) 762-766
40. Tardivel A., Tinel A., Lens S., Steiner Q.G., Sauberli E., Wilson A., et al. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF. Eur J Immunol 34 (2004) 509-518
41. Amanna I.J., Dingwall J.P., and Hayes C.E. Enforced bcl-xL gene expression restored splenic B lymphocyte development in BAFF-R mutant mice. J Immunol 170 (2003) 4593-4600
42. Sasaki Y., Casola S., Kutok J.L., Rajewsky K., and Schmidt-Supprian M. TNF family member B cell-activating factor (BAFF) receptor-dependent and -independent roles for BAFF in B cell physiology. J Immunol 173 (2004) 2245-2252
43. Shulga-Morskaya S., Dobles M., Walsh M.E., Ng L.G., MacKay F., Rao S.P., et al. B cell-activating factor belonging to the TNF family acts through separate receptors to support B cell survival and T cell-independent antibody formation. J Immunol 173 (2004) 2331-2341
44. Yan M., Wang H., Chan B., Roose-Girma M., Erickson S., Baker T., et al. Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol 2 (2001) 638-643
45. von Bulow G.U., van Deursen J.M., and Bram R.J. Regulation of the T-independent humoral response by TACI. Immunity 14 (2001) 573-582
46. Seshasayee D., Valdez P., Yan M., Dixit V.M., Tumas D., and Grewal I.S. Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor. Immunity 18 (2003) 279-288
47. Xu S., and Lam K.P. B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses. Mol Cell Biol 21 (2001) 4067-4074
48. O'Connor B.P., Raman V.S., Erickson L.D., Cook W.J., Weaver L.K., Ahonen C., et al. BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med 199 (2004) 91-98
49. Avery D.T., Kalled S.L., Ellyard J.I., Ambrose C., Bixler S.A., Thien M., et al. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J Clin Invest 112 (2003) 286-297
50. Zhang X., Park C.S., Yoon S.O., Li L., Hsu Y.M., Ambrose C., et al. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Int Immunol 17 (2005) 779-788
51. Bonizzi G., and Karin M. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25 (2004) 280-288
52. Aggarwal B.B. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3 (2003) 745-756
53. Hauer J., Puschner S., Ramakrishnan P., Simon U., Bongers M., Federle C., et al. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs. Proc Natl Acad Sci USA 102 (2005) 2874-2879
54. Claudio E., Brown K., Park S., Wang H., and Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat Immunol 3 (2002) 958-965
55. Kaisho T., Takeda K., Tsujimura T., Kawai T., Nomura F., Terada N., et al. IkappaB kinase alpha is essential for mature B cell development and function. J Exp Med 193 (2001) 417-426
56. Franzoso G., Carlson L., Xing L., Poljak L., Shores E.W., Brown K.D., et al. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev 11 (1997) 3482-3496
57. Hatada E.N., Do R.K., Orlofsky A., Liou H.C., Prystowsky M., MacLennan I.C., et al. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells. J Immunol 171 (2003) 761-768
58. Qian Y., Zhao Z., Jiang Z., and Li X.. Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cells. Proc Natl Acad Sci USA 99 (2002) 9386-9391
59. Xu Y., Cheng G., and Baltimore D. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 5 (1996) 407-415
60. Liao G., Zhang M., Harhaj E.W., and Sun S.C. Regulation of the NF-kappaB-inducing kinase by tumor necrosis factor receptor-associated factor 3-induced degradation. J Biol Chem 279 (2004) 26243-26250
61. Grech A.P., Amesbury M., Chan T., Gardam S., Basten A., and Brink R. TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. Immunity 21 (2004) 629-642
62. Ramakrishnan P., Wang W., and Wallach D. Receptor-specific signaling for both the alternative and the canonical NF-kappaB activation pathways by NF-kappaB-inducing kinase. Immunity 21 (2004) 477-489
63. Qian Y., Qin J., Cui G., Naramura M., Snow E.C., Ware C.F., et al. Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity 21 (2004) 575-587
64. Chen C., Edelstein L.C., and Gelinas C. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20 (2000) 2687-2695
65. Viatour P., Bentires-Alj M., Chariot A., Deregowski V., de Leval L., Merville M.P., et al. NF-kappa B2/p100 induces Bcl-2 expression. Leukemia 17 (2003) 1349-1356
66. Grossmann M., O'Reilly L.A., Gugasyan R., Strasser A., Adams J.M., and Gerondakis S. The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression. Embo J 19 (2000) 6351-6360
67. Glasgow J.N., Wood T., and Perez-Polo J.R. Identification and characterization of nuclear factor kappaB binding sites in the murine bcl-x promoter. J Neurochem 75 (2000) 1377-1389
68. Trescol-Biemont M.C., Verschelde C., Cottalorda A., and Bonnefoy-Berard N. Regulation of A1/Bfl-1 expression in peripheral splenic B cells. Biochimie 86 (2004) 287-294
69. Hsu B.L., Harless S.M., Lindsley R.C., Hilbert D.M., and Cancro M.P. Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J Immunol 168 (2002) 5993-5996
70. Huard B., Schneider P., Mauri D., Tschopp J., and French L.E. T cell costimulation by the TNF ligand BAFF. J Immunol 167 (2001) 6225-6231
71. Ng L.G., Sutherland A.P., Newton R., Qian F., Cachero T.G., Scott M.L., et al. B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells. J Immunol 173 (2004) 807-817
72. Ye Q., Wang L., Wells A.D., Tao R., Han R., Davidson A., et al. BAFF binding to T cell-expressed BAFF-R costimulates T cell proliferation and alloresponses. Eur J Immunol 34 (2004) 2750-2759
73. Diaz-de-Durana Y., Mantchev G.T., Bram R.J., and Franco A. TACI-BLyS signaling via B-cell-dendritic cell cooperation is required for naive CD8 + T-cell priming in vivo. Blood 107 (2006) 594-601
74. Yang M., Hase H., Legarda-Addison D., Varughese L., Seed B., and Ting A.T. B cell maturation antigen, the receptor for a proliferation-inducing ligand and B cell-activating factor of the TNF family, induces antigen presentation in B cells. J Immunol 175 (2005) 2814-2824
75. Xia X.Z., Treanor J., Senaldi G., Khare S.D., Boone T., Kelley M., et al. TACI is a TRAF-interacting receptor for TALL-1, a tumor necrosis factor family member involved in B cell regulation. J Exp Med 192 (2000) 137-143
76. Schneider P., Takatsuka H., Wilson A., Mackay F., Tardivel A., Lens S., et al. Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J Exp Med 194 (2001) 1691-1697
77. Bouillet P., Metcalf D., Huang D.C., Tarlinton D.M., Kay T.W., Kontgen F., et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286 (1999) 1735-1738
78. Craxton A., Draves K.E., Gruppi A., and Clark E.A. BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway. J Exp Med 202 (2005) 1363-1374
79. Takeuchi O., Fisher J., Suh H., Harada H., Malynn B.A., and Korsmeyer S.J. Essential role of BAX, BAK in B cell homeostasis and prevention of autoimmune disease. Proc Natl Acad Sci USA 102 (2005) 11272-11277
80. Mecklenbrauker I., Saijo K., Zheng N.Y., Leitges M., and Tarakhovsky A. Protein kinase Cdelta controls self-antigen-induced B-cell tolerance. Nature 416 (2002) 860-865
81. Mecklenbrauker I., Kalled S.L., Leitges M., Mackay F., and Tarakhovsky A. Regulation of B-cell survival by BAFF-dependent PKCdelta-mediated nuclear signaling. Nature 431 (2004) 456-461
82. Thomas M.D., Kremer C.S., Ravichandran K.S., Rajewsky K., and Bender T.P. c-Myb is critical for B cell development and maintenance of follicular B cells. Immunity 23 (2005) 275-286
83. Castigli E., Alt F.W., Davidson L., Bottaro A., Mizoguchi E., Bhan A.K., et al. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci USA 91 (1994) 12135-12139
84. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3 (2002) 822-829
85. Castigli E., Wilson S.A., Scott S., Dedeoglu F., Xu S., Lam K.P., et al. TACI and BAFF-R mediate isotype switching in B cells. J Exp Med 201 (2005) 35-39
86. Messner B., Stutz A.M., Albrecht B., Peiritsch S., and Woisetschlager M. Cooperation of binding sites for STAT6 and NF kappa B/rel in the IL-4-induced up-regulation of the human IgE germline promoter. J Immunol 159 (1997) 3330-3337
87. Castigli E., Scott S., Dedeoglu F., Bryce P., Jabara H., Bhan A.K., et al. Impaired IgA class switching in APRIL-deficient mice. Proc Natl Acad Sci USA 101 (2004) 3903-3908
88. Varfolomeev E., Kischkel F., Martin F., Seshasayee D., Wang H., Lawrence D., et al. APRIL-deficient mice have normal immune system development. Mol Cell Biol 24 (2004) 997-1006
89. Khare S.D., Sarosi I., Xia X.Z., McCabe S., Miner K., Solovyev I., et al. Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc Natl Acad Sci USA 97 (2000) 3370-3375
90. Salzer U., Chapel H.M., Webster A.D., Pan-Hammarstrom Q., Schmitt-Graeff A., Schlesier M., et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 37 (2005) 820-828
91. Castigli E., Wilson S.A., Garibyan L., Rachid R., Bonilla F., Schneider L., et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37 (2005) 829-834
92. Tran D.D., Russell H.R., Sutor S.L., van Deursen J., and Bram R.J. CAML is required for efficient EGF receptor recycling. Dev Cell 5 (2003) 245-256
93. Tran D.D., Edgar C.E., Heckman K.L., Sutor S.L., Huntoon C.J., van Deursen J., et al. CAML is a p56Lck-interacting protein that is required for thymocyte development. Immunity 23 (2005) 139-152
94. Losi C.G., Silini A., Fiorini C., Soresina A., Meini A., Ferrari S., et al. Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency. J Clin Immunol 25 (2005) 496-502
95. Fagarasan S., and Honjo T. T-Independent immune response: new aspects of B cell biology. Science 290 (2000) 89-92
96. Yamada T., Zhang K., Yamada A., Zhu D., and Saxon A. B lymphocyte stimulator activates p38 mitogen-activated protein kinase in human Ig class switch recombination. Am J Respir Cell Mol Biol 32 (2005) 388-394
97. Hase H., Kanno Y., Kojima M., Hasegawa K., Sakurai D., Kojima H., et al. BAFF/BLyS can potentiate B-cell selection with the B-cell coreceptor complex. Blood 103 (2004) 2257-2265
98. Planelles L., Carvalho-Pinto C.E., Hardenberg G., Smaniotto S., Savino W., Gomez-Caro R., et al. APRIL promotes B-1 cell-associated neoplasm. Cancer Cell 6 (2004) 399-408
99. Day E.S., Cachero T.G., Qian F., Sun Y., Wen D., Pelletier M., et al. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Biochemistry 44 (2005) 1919-1931